Showing results (191-200 of 221) with videos related to

Sort By:
Pageof 23
Scientific Reports|August 4, 2016
Visual Outcome and Related Factors in Bilateral Total Congenital Cataract Patients: A Prospective Cohort StudyLi Zhang, Xiaohang Wu, Duoru Lin, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 21, 2019
Controlled release of corticosteroid with biodegradable nanoparticles for treating experimental autoimmune uveitisLixia Luo, Jin Yang, Yumin Oh, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2023
56 Fe ion exposure increases the incidence of lung and brain tumors at a similar rate in male and female miceSophie R Finkelstein, Rutulkumar Patel, Katherine Deland, et al.
Radiation Research|November 1, 2021
Sensitization of Endothelial Cells to Ionizing Radiation Exacerbates Delayed Radiation Myelopathy in MiceChang-Lung Lee, Ato O Wright, Jessica W Lee, et al.
JCI Insight|May 22, 2019
Mutational landscape in genetically engineered, carcinogen-induced, and radiation-induced mouse sarcomaChang-Lung Lee, Yvonne M Mowery, Andrea R Daniel, et al.
Radiation Research|September 22, 2024
56Fe-ion Exposure Increases the Incidence of Lung and Brain Tumors at a Similar Rate in Male and Female MiceSophie R Finkelstein, Rutulkumar Patel, Katherine Deland, et al.
Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)|July 31, 2023
Impact of Cataract Surgery on Income in Rural Southern China: The SUCCESS Randomized Controlled TrialXuhua Tan, Xiaotong Han, Yingfeng Zheng, et al.
The Journal of Clinical Investigation|May 18, 2023
Atrx deletion impairs CGAS/STING signaling and increases sarcoma response to radiation and oncolytic herpesvirusWarren Floyd, Matthew Pierpoint, Chang Su, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2025
Nrf2 hyperactivation as a driver of radiotherapy resistance and suppressed anti-tumor immunity in head and neck squamous cell carcinomaRutulkumar Patel, Kalil Saab, Lixia Luo, et al.
International Journal of Radiation Oncology, Biology, Physics|December 17, 2023
Preclinical Evaluation of the ATR Inhibitor BAY 1895344 as a Radiosensitizer for Head and Neck Squamous Cell CarcinomaDiana A Odhiambo, Allison N Pittman, Ashlyn G Rickard, et al.
Pageof 23